Alabama
Roll Tide: Lilly selects Alabama site as location for $6B API facility
Eli Lilly has unveiled the location of the third of its four large-scale manufacturing facilities that it plans to build in the U.S. | Eli Lilly has unveiled the location of the third of its four large-scale manufacturing facilities that it plans to build in the U.S. The drugmaker has selected Huntsville, Alabama, as the site of a $6 billion plant that will produce APIs for small molecule and peptide medicines.